1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow SARS-CoV-2 convalescent plasma: new trials by email Literature Review of SARS-CoV-2 convalescent plasma trials Research Report on SARS-CoV-2 convalescent plasma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19 SARS-CoV-2 convalescent plasma - Covid19, Immuno-Deficiency | Phase 3 | Unknown | University Hospital, Geneva | 100 | 2021-04-08 | 2021-04-08 |
| Convalescent Plasma for Treatment of COVID-19 SARS-CoV-2 convalescent plasma, Standard of care - Covid19 | Phase 2 / Phase 3 | Completed | Joakim Dillner | 59 | 2020-12-03 | 2022-02-09 |
COVID-19 (2) · Frailty (1) · Viremia (1)
Joakim Dillner (1) · University Hospital, Geneva (1)
Sweden (1) · Switzerland (1)
Enos Bernasconi, MD (1) · Laurent Kaiser, MD (1) · Maja Weisser, MD (1)